8-K
Current Report
CRISPR Therapeutics AG Filed Acc 0001193125-18-281385
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading d626868d8k.htm…
CRISPR Therapeutics AG Filed Acc 0001193125-18-281385
Material agreement
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…